Obstetrics, Gynecology and Reproductive Biology Research
Ironwood Study
A Phase 2 Study of IW‑3300 for the Treatment of Bladder Pain in Subjects with Interstitial Cystitis/Bladder Pain Syndrome
This study is currently closed to enrollment.
AGE: 18+ years old
GENDER: Female
HEALTHY PARTICIPANTS: No
GENDER: Female
HEALTHY PARTICIPANTS: No
TYPE: Interventional Treatment
CONDITION: Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS)
CONDITION: Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS)
LOCATION: University Hospitals Medical Centers
COMPENSATION: Yes
COMPENSATION: Yes
Study Purpose
The purpose of this study is to assess the efficacy, safety, and tolerability of IW‑3300, an investigational drug for the treatment for interstitial cystitis/bladder pain syndrome (IC/BPS) administered once daily as a rectal foam.
Who Can Participate
Premenopausal women 18 years of age or older with interstitial cystitis/bladder pain syndrome may be eligible for this study.
- STUDY20230606
- SITE00002000